Role of Selected Antioxidants (Vitamin C and E) in the Management of Schizophrenia
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 105
- Locations
- 1
- Primary Endpoint
- Positive and Negative Syndrome Scale
Study Overview
Brief Summary
Background: Antioxidants are substances that are considered as a defensive material which protects cells from destruction. It is evident that use of food stuff rich in antioxidant will fortify one's ability to encounter with physical & mental disorders. Since, among several potential elucidations, oxidative stress is more likely deliberated as one of the causative factors which give rise to cognitive and functional impairment. This deterioration further result in intricacy in ones thought process as progressive brain changes crop-up schizophrenic unfold. Therefore, this study was conducted with objectives to explore the role of selected antioxidants (vitamin C & E) and to compare the role of both vitamins as an add-on management of schizophrenia .Materials & Methods: One hundred and five patients were selected from department of psychiatry King Edward Medical University Lahore, and assigned into 3 groups by simple random lottery method. For eight weeks, Vitamin C group intervened with 500mg vitamin C tablet once a day, vitamin E group with 600IU vitamin E twice daily and placebo group was given 500 mg paraffin oil capsule daily. PANSS scale was used to assess the symptoms of schizophrenia. Demographic information was collected by structured questionnaire. Dietary habits were assessed by food frequency questionnaire.
Detailed Description
Background: Antioxidants such as Vitamin C and E are substances that are considered as a defensive material which protects cells from destruction. It is evident that use of food stuff rich in antioxidant will fortify one's ability to encounter with physical & mental disorders. Since, among several potential elucidations, oxidation stress is more likely deliberated as one of the causative factors which give rise to cognitive and functional impairment. Therefore, this study was conducted with objectives to explore the role of selected antioxidants (vitamin C & E) and to compare the role of both vitamins as an add-on management of schizophrenia .Materials & Methods: One hundred and five patients were selected from department of psychiatry King Edward Medical University Lahore, and assigned into 3 groups by simple random lottery method. For the period of two months, Vitamin C group intervened with 500 mg vitamin C tablet once a day, vitamin E group with 600 I U vitamin E twice daily and placebo group was given 500 mg paraffin oil capsule daily. PANSS (Positive and Negative Symptoms Scale) was used to assess the symptoms of schizophrenia. Demographic information was collected by structured questionnaire. Dietary habits were assessed by (FFQ) food frequency questionnaire.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Factorial
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 50 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •INCLUSION CRITERIA:
- •All diagnosed schizophrenic patients 20-50 years of age
- •visited department of psychiatry & behavioral sciences King Edward medical university Lahore.
Exclusion Criteria
- •Patients diagnosed with axis i and axis ii disorders
- •having any other pathological condition like hypertension, hyperlipidemia, and cardiac disorders.
- •Exclusion Criteria:
Arms & Interventions
Vitamin C Group
Tablet Vitamin C 500 mg Once a day
Intervention: Antioxidants (Vitamin C, E ) (Dietary Supplement)
Vitamin E Group
Tablet Vitamin E 600 I U Twice daily
Intervention: Antioxidants (Vitamin C, E ) (Dietary Supplement)
Placebo Group
Capsule Paraffin oil 500 mg Once a day
Intervention: Antioxidants (Vitamin C, E ) (Dietary Supplement)
Outcomes
Primary Outcomes
Positive and Negative Syndrome Scale
Time Frame: 45-50 minutes
The Positive and Negative Syndrome Scale (PANSS) is a medical scale used for measuring symptom severity of patients with schizophrenia.The PANSS yields a total average symptom score, based on 30 items rated from one to seven (range=30-210). Higher scores indicate more severe symptoms.
Secondary Outcomes
No secondary outcomes reported
Investigators
Saima Zahid
Principal Investigator
University of Health Sciences Lahore